CA
NZ
UK
AU
IND
US
Natera, Inc. Chief Financial Officer Brophy Michael Burkes filed a Form 4 on October 30, 2026, disclosing the sale of a combined 3,084 shares of common stock across three transactions between October 28 and October 30, 2026, under a pre-established Rule 10b5-1 trading plan.
JANA Partners Management, LP filed Amendment No. 2 to its Schedule 13D with the SEC on October 30, 2026, disclosing a reduced beneficial ownership position in Alkami Technology, Inc. common stock as of October 28, 2026.
Glenbrook Capital Management filed a Form 4 with the SEC on October 30, 2026, disclosing two open-market purchases of SenesTech, Inc. common stock totaling 30,000 shares on October 28 and October 30, 2026.
Glenbrook Capital Management filed Amendment No. 3 to its Schedule 13D with the SEC on October 30, 2026, disclosing updated beneficial ownership and a previously undisclosed minority interest in a newly engaged strategic advisor to SenesTech, Inc.
Francis Knuettel II, Chief Financial Officer of OS Therapies Inc, filed a Form 4 on October 30, 2026, disclosing the grant of 300,000 stock options on October 22, 2026, and an indirect holding of 20,000 shares of common stock through the Lara Knuettel Revocable …
OS Therapies Inc Chief Commercial Officer Kerry M. Clem filed a Form 4 on October 30, 2026, disclosing the grant of stock options to purchase 300,000 shares of common stock on October 22, 2026.
Director Christopher R. Moe of Red Cat Holdings, Inc. filed a Form 4 on October 30, 2026, reporting the acquisition of two tranches of restricted stock units in RCAT common stock on October 28, 2026.
Director Craig Eagle of OS Therapies Inc filed a Form 4 on October 30, 2026, disclosing the grant of stock options to purchase 300,000 shares of common stock on October 22, 2026.
Director Olivier Roger Jarry filed a Form 4 with the SEC on October 30, 2026, disclosing the grant of stock options to purchase 300,000 shares of OS Therapies Inc common stock on October 22, 2026.
Belite Bio, Inc. Chief Executive Officer and Director Lin Yu-Hsin filed a statement of changes in beneficial ownership on October 30, 2026, reporting the vesting of 5,000 ordinary shares under a restricted stock unit award originally granted on September 15, 2025.
Please wait processing your request...